Language Performance in Postmenopausal Women with and Without Hormone Therapy and Men

Overview

Journal Aging health

Publisher Future Medicine

Specialty Geriatrics

Date 2015 Feb 24

PMID 25705244

Authors

Grace J Lee

Ashley R Curiel

Karen J Miller

Stacy Amano

Richard Gorsuch

Gary W Small

Affiliations

Soon will be listed here.

Abstract

Aims: In the current study, we explored the potential effects of hormone therapy (HT) on language functioning in healthy, postmenopausal women and compared them with men of similar ages.

Materials & Methods: Language functioning on tasks of verbal fluency and object naming was examined in 100 participants (mean age: 61.9 years; 33 HT users, 15 HT non-users and 52 men) at baseline and follow-up (mean follow-up time period: 2.6 years).

Results: At baseline, men had higher composite language scores than HT users. However, HT users demonstrated more improvement over time compared with men, whereas HT non-users performed similarly to men, with no improvement over time. Longer duration of HT use was not associated with improved performance on language tests.

Conclusion: These results suggest an association between HT use and better language ability in postmenopausal women.

References

Chen S, Nilsen J, Brinton R . Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology. 2006; 147(11):5303-13. DOI: 10.1210/en.2006-0495. View

Buschke H, Fuld P . Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974; 24(11):1019-25. DOI: 10.1212/wnl.24.11.1019. View

Sherwin B . The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?. J Neuroendocrinol. 2007; 19(2):77-81. DOI: 10.1111/j.1365-2826.2006.01508.x. View

Miller K, Conney J, Rasgon N, Fairbanks L, Small G . Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc. 2002; 50(11):1826-30. DOI: 10.1046/j.1532-5415.2002.50511.x. View

Toran-Allerand C, Miranda R, Bentham W, Sohrabji F, Brown T, Hochberg R . Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A. 1992; 89(10):4668-72. PMC: 49144. DOI: 10.1073/pnas.89.10.4668. View

Craig M, Murphy D . Alzheimer's disease in women. Best Pract Res Clin Obstet Gynaecol. 2008; 23(1):53-61. DOI: 10.1016/j.bpobgyn.2008.10.004. View

Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N . Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J. 1994; 41(4):361-71. DOI: 10.1507/endocrj.41.361. View

Garrard P, Lambon Ralph M, Patterson K, Pratt K, Hodges J . Semantic feature knowledge and picture naming in dementia of Alzheimer's type: a new approach. Brain Lang. 2005; 93(1):79-94. DOI: 10.1016/j.bandl.2004.08.003. View

McEwen B . Estrogen actions throughout the brain. Recent Prog Horm Res. 2002; 57:357-84. DOI: 10.1210/rp.57.1.357. View

10.

Henderson V . Cognitive changes after menopause: influence of estrogen. Clin Obstet Gynecol. 2008; 51(3):618-26. PMC: 2637911. DOI: 10.1097/GRF.0b013e318180ba10. View

11.

Mulnard R, Cotman C, Kawas C, van Dyck C, Sano M, Doody R . Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000; 283(8):1007-15. DOI: 10.1001/jama.283.8.1007. View

12.

Rapp S, Espeland M, Shumaker S, Henderson V, Brunner R, Manson J . Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289(20):2663-72. DOI: 10.1001/jama.289.20.2663. View

13.

Miller K, Rogers S, Siddarth P, Small G . Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease. Int J Geriatr Psychiatry. 2005; 20(2):128-36. DOI: 10.1002/gps.1262. View

14.

Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A . A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997; 48(6):1517-21. DOI: 10.1212/wnl.48.6.1517. View

15.

Tang M, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B . Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996; 348(9025):429-32. DOI: 10.1016/S0140-6736(96)03356-9. View

16.

Guvenal T, Durna A, Erden O, Guvenal F, Cetin M, Cetin A . Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions. Adv Ther. 2009; 26(8):805-11. DOI: 10.1007/s12325-009-0058-x. View

17.

Shumaker S, Legault C, Rapp S, Thal L, Wallace R, Ockene J . Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289(20):2651-62. DOI: 10.1001/jama.289.20.2651. View

18.

Resnick S, Maki P, Golski S, Kraut M, Zonderman A . Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav. 1998; 34(2):171-82. DOI: 10.1006/hbeh.1998.1476. View

19.

Rice M, Graves A, McCurry S, Gibbons L, Bowen J, McCormick W . Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project. Arch Intern Med. 2000; 160(11):1641-9. DOI: 10.1001/archinte.160.11.1641. View

20.

Wolf O, Heinrich A, Hanstein B, Kirschbaum C . Estradiol or estradiol/progesterone treatment in older women: no strong effects on cognition. Neurobiol Aging. 2005; 26(7):1029-33. DOI: 10.1016/j.neurobiolaging.2004.09.012. View